发明名称 |
Therapy-enhancing glucan |
摘要 |
This invention provides a composition comprising an effective amount of glucan capable of enhancing efficacy of antibodies. This invention further provides the above compositions and a pharmaceutically acceptable carrier. This invention also provides a method for treating a subject with cancer comprising administrating the above-described composition to the subject. This invention provides a composition comprising effective amount of glucan capable of enhancing efficacy of vaccines. This invention also provides a method of treating a subject comprising administrating the above pharmaceutical composition to the subject. This invention provides a composition comprising effective amount of glucan capable of enhancing efficacy of natural antibodies. This invention provides a composition comprising effective amount of glucan capable of enhancing host immunity. This invention also provides a composition comprising effective amount of glucan capable of enhancing the action of an agent in preventing tissue rejection. |
申请公布号 |
US8791252(B2) |
申请公布日期 |
2014.07.29 |
申请号 |
US201313859096 |
申请日期 |
2013.04.09 |
申请人 |
Sloan-Kettering Institute for Cancer Research |
发明人 |
Cheung Nai-Kong V. |
分类号 |
A61K31/716;C08B37/18;C08B37/00 |
主分类号 |
A61K31/716 |
代理机构 |
Law Offices of Albert Wai-Kit Chan, PLLC |
代理人 |
Law Offices of Albert Wai-Kit Chan, PLLC |
主权项 |
1. A method of treating cancer in a subject, comprising:
(a) administering a complement-activating antibody to said subject, and (b) orally administering to said subject a β-(1,3)-glucan in an amount effective to enhance the anti-tumor effect of said antibody, wherein said antibody and said glucan alone has little or no effect on said cancer, and wherein said glucan has a molecular weight from about 40,000 to about 359,000 Daltons. |
地址 |
New York NY US |